Savara Inc (NASDAQ: SVRA) had its price target lowered by analysts at HC Wainwright from $10.00 to $6.00. They now have a "buy" rating on the stock.
Savara Announces Participation in Upcoming Healthcare Conferences [Yahoo! Finance]
Savara Inc (NASDAQ: SVRA) had its "in-line" rating re-affirmed by analysts at Evercore ISI. They now have a $5.00 price target on the stock, down previously from $7.00.
Savara Announces Participation in Upcoming Healthcare Conferences
Savara Reports Third Quarter 2024 Financial Results and Provides Business Update